Sveriges mest populära poddar
The Rest Is Money
NyheterNäringsliv

2. The drug behind Europe's most valuable company

57 min•6 september 2023

How much harm has been done by decades of governments investing too little? Is buy-now-pay-later causing misery or joy for young shoppers? Are supermarkets cutting prices fast enough? Is Novo Nordisk’s anti obesity wonder drug Semaglutide the most important pharmaceutical discovery of the century?


Join Robert and Steph as they answer all these questions and more on today's episode of The Rest Is Money.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Fler avsnitt av The Rest Is Money

Visa alla avsnitt av The Rest Is Money
309. Why we’re wasting our time predicting the future of AI
•46 min
308. The 4 challenges (and the biggest opportunity) facing the new PM
•47 min
307. The world’s most influential economist: how we can deliver "worker-friendly AI"
•26 min
306. The world’s most influential economist: Tax wealth and break up big tech
•32 min
305. The Apprentice Unicorn - Euan Blair on rewiring investment and training
•45 min
304. Why Burnham’s best economic policy would be “do nothing”
•50 min
303. Why making schools truly comprehensive is vital for our economy
•1 tim 2 min
302. Can the West bridge the gap with China, India and the BRICs+ nations?
•38 min
301. Why the US won't stop China in the AI race
•52 min
300. Does Burnham get AI?
•43 min

The Rest Is Money med Goalhanger finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.